519 related articles for article (PubMed ID: 28245856)
1. Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients.
Galloway-Peña JR; Smith DP; Sahasrabhojane P; Wadsworth WD; Fellman BM; Ajami NJ; Shpall EJ; Daver N; Guindani M; Petrosino JF; Kontoyiannis DP; Shelburne SA
Genome Med; 2017 Feb; 9(1):21. PubMed ID: 28245856
[TBL] [Abstract][Full Text] [Related]
2. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia.
Galloway-Peña JR; Smith DP; Sahasrabhojane P; Ajami NJ; Wadsworth WD; Daver NG; Chemaly RF; Marsh L; Ghantoji SS; Pemmaraju N; Garcia-Manero G; Rezvani K; Alousi AM; Wargo JA; Shpall EJ; Futreal PA; Guindani M; Petrosino JF; Kontoyiannis DP; Shelburne SA
Cancer; 2016 Jul; 122(14):2186-96. PubMed ID: 27142181
[TBL] [Abstract][Full Text] [Related]
3. Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients.
Franklin S; Aitken SL; Shi Y; Sahasrabhojane PV; Robinson S; Peterson CB; Daver N; Ajami NA; Kontoyiannis DP; Shelburne SA; Galloway-Peña J
Front Cell Infect Microbiol; 2022; 12():848580. PubMed ID: 35433514
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia.
Galloway-Peña JR; Shi Y; Peterson CB; Sahasrabhojane P; Gopalakrishnan V; Brumlow CE; Daver NG; Alfayez M; Boddu PC; Khan MAW; Wargo JA; Do KA; Jenq RR; Kontoyiannis DP; Shelburne SA
Clin Infect Dis; 2020 Jun; 71(1):63-71. PubMed ID: 31436833
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal microbial populations can distinguish pediatric and adolescent Acute Lymphoblastic Leukemia (ALL) at the time of disease diagnosis.
Rajagopala SV; Yooseph S; Harkins DM; Moncera KJ; Zabokrtsky KB; Torralba MG; Tovchigrechko A; Highlander SK; Pieper R; Sender L; Nelson KE
BMC Genomics; 2016 Aug; 17(1):635. PubMed ID: 27527070
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the Oral and Gastrointestinal Microbiomes to Bloodstream Infections in Leukemia Patients.
McMahon S; Sahasrabhojane P; Kim J; Franklin S; Chang CC; Jenq RR; Hillhouse AE; Shelburne SA; Galloway-Peña J
Microbiol Spectr; 2023 Jun; 11(3):e0041523. PubMed ID: 37022173
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiome Composition Predicts Infection Risk During Chemotherapy in Children With Acute Lymphoblastic Leukemia.
Hakim H; Dallas R; Wolf J; Tang L; Schultz-Cherry S; Darling V; Johnson C; Karlsson EA; Chang TC; Jeha S; Pui CH; Sun Y; Pounds S; Hayden RT; Tuomanen E; Rosch JW
Clin Infect Dis; 2018 Aug; 67(4):541-548. PubMed ID: 29518185
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection.
Montassier E; Al-Ghalith GA; Ward T; Corvec S; Gastinne T; Potel G; Moreau P; de la Cochetiere MF; Batard E; Knights D
Genome Med; 2016 Apr; 8(1):49. PubMed ID: 27121964
[TBL] [Abstract][Full Text] [Related]
9. Observational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia.
Robinson S; Peterson CB; Sahasrabhojane P; Ajami NJ; Shelburne SA; Kontoyiannis DP; Galloway-Peña JR
mSphere; 2020 Apr; 5(2):. PubMed ID: 32295867
[TBL] [Abstract][Full Text] [Related]
10. Characterization of microbiota in acute leukemia patients following successful remission induction chemotherapy without antimicrobial prophylaxis.
Shen Z; Gu X; Cao H; Mao W; Yang L; He M; Zhang R; Zhou Y; Liu K; Wang L; Liu L; Yu J; Yin L
Int Microbiol; 2021 May; 24(2):263-273. PubMed ID: 33604753
[TBL] [Abstract][Full Text] [Related]
11. The gut mycobiome of the Human Microbiome Project healthy cohort.
Nash AK; Auchtung TA; Wong MC; Smith DP; Gesell JR; Ross MC; Stewart CJ; Metcalf GA; Muzny DM; Gibbs RA; Ajami NJ; Petrosino JF
Microbiome; 2017 Nov; 5(1):153. PubMed ID: 29178920
[TBL] [Abstract][Full Text] [Related]
12. Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces.
Zaura E; Brandt BW; Teixeira de Mattos MJ; Buijs MJ; Caspers MP; Rashid MU; Weintraub A; Nord CE; Savell A; Hu Y; Coates AR; Hubank M; Spratt DA; Wilson M; Keijser BJ; Crielaard W
mBio; 2015 Nov; 6(6):e01693-15. PubMed ID: 26556275
[TBL] [Abstract][Full Text] [Related]
13. Temporal Variability and Stability of the Fecal Microbiome: The Multiethnic Cohort Study.
Fu BC; Randolph TW; Lim U; Monroe KR; Cheng I; Wilkens LR; Le Marchand L; Lampe JW; Hullar MAJ
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):154-162. PubMed ID: 30206059
[TBL] [Abstract][Full Text] [Related]
14. Rectal Swabs from Critically Ill Patients Provide Discordant Representations of the Gut Microbiome Compared to Stool Samples.
Fair K; Dunlap DG; Fitch A; Bogdanovich T; Methé B; Morris A; McVerry BJ; Kitsios GD
mSphere; 2019 Jul; 4(4):. PubMed ID: 31341070
[TBL] [Abstract][Full Text] [Related]
15. Impact of Antibiotic Gut Exposure on the Temporal Changes in Microbiome Diversity.
Burdet C; Nguyen TT; Duval X; Ferreira S; Andremont A; Guedj J; Mentré F;
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307985
[TBL] [Abstract][Full Text] [Related]
16. Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas.
Wang H; Funchain P; Bebek G; Altemus J; Zhang H; Niazi F; Peterson C; Lee WT; Burkey BB; Eng C
Genome Med; 2017 Feb; 9(1):14. PubMed ID: 28173873
[TBL] [Abstract][Full Text] [Related]
17. Capturing the diversity of the human gut microbiota through culture-enriched molecular profiling.
Lau JT; Whelan FJ; Herath I; Lee CH; Collins SM; Bercik P; Surette MG
Genome Med; 2016 Jul; 8(1):72. PubMed ID: 27363992
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbial Diversity in Antibiotic-Naive Children After Systemic Antibiotic Exposure: A Randomized Controlled Trial.
Doan T; Arzika AM; Ray KJ; Cotter SY; Kim J; Maliki R; Zhong L; Zhou Z; Porco TC; Vanderschelden B; Keenan JD; Lietman TM
Clin Infect Dis; 2017 May; 64(9):1147-1153. PubMed ID: 28402408
[TBL] [Abstract][Full Text] [Related]
19. Oral microbiome alterations of healthy volunteers with proton pump inhibitor.
Mishiro T; Oka K; Kuroki Y; Takahashi M; Tatsumi K; Saitoh T; Tobita H; Ishimura N; Sato S; Ishihara S; Sekine J; Wada K; Kinoshita Y
J Gastroenterol Hepatol; 2018 May; 33(5):1059-1066. PubMed ID: 29105152
[TBL] [Abstract][Full Text] [Related]
20. Temporal bacterial and metabolic development of the preterm gut reveals specific signatures in health and disease.
Stewart CJ; Embleton ND; Marrs EC; Smith DP; Nelson A; Abdulkadir B; Skeath T; Petrosino JF; Perry JD; Berrington JE; Cummings SP
Microbiome; 2016 Dec; 4(1):67. PubMed ID: 28034304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
